Drugmaker Wockhardt has been asked by authorities in Himachal Pradesh to stop selling three drugs, the company said, without giving reasons.
In a statement to the stock exchange, the company said the HP drug controller has suspended the manufacture, sale or distribution of fixed dose combination drugs – Dicyclomine Hydrochloride IP 10mg (for irritable bowel syndrome), Tramadol Hydrochloride (for pain) IP 50mg and Acetamenophen IP 325mg (for pain and fever).
Wockhardt said it would file an appeal before the State Government to get the suspension revoked. Business Line
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…